Yahoo
NYSE - Delayed Quote USD

BlackRock Health Sciences Trust (BME)

46.87 +0.13 (+0.28%)
At close: October 30 at 4:00:02 PM EDT
Trade BME on Coinbase
Chart Range Bar
Loading chart for BME
  • Previous Close 46.74
  • Open 47.10
  • Bid 46.64 x 20000
  • Ask 46.81 x 10000
  • Day's Range 46.55 - 47.37
  • 52 Week Range 37.51 - 47.38
  • Volume 65,625
  • Avg. Volume 41,068
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 5.82
  • EPS (TTM) 8.06
  • Earnings Date --
  • Forward Dividend & Yield 3.15 (6.71%)
  • Ex-Dividend Date Nov 13, 2026
  • 1y Target Est --

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund

--

Full Time Employees

December 31

Fiscal Year Ends

Asset Management

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BME
21.32%
S&P 500 (^GSPC)
10.73%

1-Year Return

BME
32.08%
S&P 500 (^GSPC)
11.11%

3-Year Return

BME
63.86%
S&P 500 (^GSPC)
81.91%

5-Year Return

BME
37.45%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1,371.16%

  • Return on Assets (ttm)

    0.20%

  • Return on Equity (ttm)

    19.27%

  • Revenue (ttm)

    7.59M

  • Net Income Avi to Common (ttm)

    104.01M

  • Diluted EPS (ttm)

    8.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    361

  • Total Debt/Equity (mrq)

    0.12%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: